指南与共识淋巴瘤造血干细胞移植与细胞治疗

外周T细胞淋巴瘤中的异基因造血细胞移植:EBMT实践协调与指南委员会推荐

Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee.
指南 / 共识 · Lancet Haematol · 2025-01-01

欧洲血液与骨髓移植学会(EBMT)实践协调与指南委员会于2024年9月30日至10月1日在法国里尔召开国际专家会议,基于文献检索、专家意见和临床经验制定外周T细胞淋巴瘤异基因造血细胞移植(HCT)推荐,旨在帮助确立异基因HCT作为符合条件的难治或复发患者的标准治疗。

要点

  • EBMT实践协调与指南委员会召开国际专家会议制定外周T细胞淋巴瘤异基因HCT推荐。
  • 推荐基于当前证据、专家意见和临床经验制定并获批。
  • 推荐旨在帮助确立异基因HCT作为符合条件的难治或复发外周T细胞淋巴瘤患者的标准治疗。

核心结论

  • 推荐应有助于进一步确立异基因HCT作为符合条件的难治或复发外周T细胞淋巴瘤患者的标准治疗,通过移植物抗淋巴瘤效应发挥其治愈潜力。

研究设计与样本

  • 欧洲血液与骨髓移植学会(EBMT)实践协调与指南委员会于2024年9月30日至10月1日在法国里尔召开国际专家会议制定推荐。
  • EBMT完成资金获取,主席邀请T细胞淋巴瘤和HCT专家,分为外周T细胞淋巴瘤和移植两个工作组。
  • 事先进行文献检索,由两或三名专家组成的小组展示结果,随后在结构化讨论和共识构建活动中集体讨论。

主要发现

  • 本综述提出的推荐基于当前证据、专家意见和临床经验制定并获批。

临床怎么用

  • 推荐应有助于进一步确立异基因HCT作为符合条件的难治或复发外周T细胞淋巴瘤患者的标准治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Allogeneic haematopoietic cell transplantation (HCT) is a potentially curative therapy for peripheral T-cell lymphoma; however, to date, there are no standardised and detailed guidelines for its application. To address gaps in clinical practice, the European Society for Blood and Marrow Transplantation (EBMT) Practice Harmonisation and Guidelines Committee convened an international expert meeting in Lille (France) on Sept 30 and Oct 1, 2024. EBMT performed funding acquisition. The chairs invited experts in T-cell lymphoma and HCT, who were organised in two work packages devoted to peripheral T-cell lymphoma and transplantation. A literature search was performed beforehand, and results were presented by subgroups of two or three experts, then discussed collectively in structured discussions, and consensus-building exercises. The recommendations presented in this Review were developed and approved based on current evidence, expert opinion, and clinical experience. These recommendations should help to further establish allogeneic HCT as the standard of care for eligible patients with refractory or relapsed peripheral T-cell lymphoma, leveraging its curative potential through the graft-versus-lymphoma effect.

来源:Lancet Haematol,查看原文。版权归原作者所有。

引用

  1. Damaj G, Bazarbachi A, Berning P, et al. Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee. Lancet Haematol. 2025. PMID: 40610175. doi:10.1016/S2352-3026(25)00073-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。